Evidence map›Paper›PMID 42479114›Full record

ArticleHuman cell2026

Comprehensive genomic analysis of five kindreds with multiple childhood leukemias: importance of individual functional analysis for rare ETV6 germline variants.

Ai Yamada, Shun Nagasawa, Midori Nakagawa, Sachiyo Kamimura, Nami Inoue, Hiroyoshi Watanabe, Masatoshi Takagi, Yuhki Koga, Dai Keino, Hideki Nakayama and 5 more

Abstract read
In one paragraph

Article in Human cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ai YamadaDivision of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.ORCID http://orcid.org/0000-0002-1888-3273
Shun NagasawaDivision of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Midori NakagawaDivision of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Sachiyo KamimuraDivision of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Nami InoueDepartment of Pediatrics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Hiroyoshi WatanabeDepartment of Pediatrics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Masatoshi TakagiDepartment of Pediatrics and Developmental Biology, Institute of Science Tokyo, Tokyo, Japan.
Yuhki KogaDepartment of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Dai KeinoDepartment of Pediatrics, St. Marianna University School of Medicine, Kanagawa, Japan.
Hideki NakayamaDepartment of Pediatrics, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Jun YoshimuraGraduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
Koichiro DoiSchool of Bioscience and Biotechnology, Tokyo University of Technology, Tokyo, Japan.
Jun MitsuiDepartment of Molecular Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Shoji TsujiDepartment of Molecular Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Hiroshi MoritakeDivision of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan. hiroshi_moritake@med.miyazaki-u.ac.jp.ORCID http://orcid.org/0000-0001-5471-7646

Funding

Japan Society for the Promotion of Science 221S0002Kaken Pharmaceutical 16K10032Kaken Pharmaceutical 25461600
6 · The paper itself

Abstract

Germline variants in leukemia predisposition genes are increasingly detected in pediatric patients. Nevertheless, the rare variants identified in diagnostic samples may be misinterpreted without variant-level functional evaluation and cautious clinical interpretation. Whole-exome sequencing was performed on 28 individuals from five kindreds in which at least two children developed acute leukemia. Results identified a rare ETV6 variant, c.604C > G (p.Arg202Gly), in monozygotic twins with ETV6::RUNX1-positive B-cell precursor acute lymphoblastic leukemia. To support variant interpretation, HeLa-cell populations stably expressing FLAG-tagged wild-type ETV6 and p.Arg202Gly and the known loss-of-function control p.Pro214Leu were established. Subcellular localization was assessed via immunofluorescence microscopy with quantitative scoring. Transcriptional repression was evaluated using luciferase reporter assays driven by ETV6 target promoters (MMP3 and PF4). p.Arg202Gly predominantly showed nuclear localization comparable to WT, whereas p.Pro214Leu was enriched in the cytoplasm. In the reporter assays, similar to WT, p.Arg202Gly retained repression activity. Meanwhile, p.Pro214Leu failed to repress both reporters. The in-silico prediction of nuclear export sequences suggested an additional export signal in p.Pro214Leu, but not in p.Arg202Gly. Collectively, these findings indicate that p.Arg202Gly behaves as WT-like in the assays performed and do not support a loss-of-function effect. Our study emphasizes the importance of variant-level functional assessment for rare ETV6 variants to inform clinical interpretation and avoid overestimation of pathogenicity.

Indexed as

Genetic Predisposition to DiseaseGenomicsGerm-Line MutationPrecursor Cell Lymphoblastic Leukemia-LymphomaProto-Oncogene Proteins c-etsRepressor ProteinsChildETS Translocation Variant 6 ProteinFemaleHeLa CellsHumansMaleETS Translocation Variant 6 ProteinProto-Oncogene Proteins c-etsRepressor ProteinsChildhood leukemiaETV6 germline variantFunctional assayLuciferase reporter assaySubcellular localization

Identifiers

PMID42479114
PMCPMC13388546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.